Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -7.48 % |
3 Month Return | + 35.21 % |
1 Year Return | + 88.86 % |
Market Stats | |
Previous Close | ₹170.45 |
Open | ₹173.90 |
Volume | 8,278.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹195.77Cr |
P/E Ratio | 16.42 |
PEG Ratio | 10.95 |
Market Cap | ₹195.77 Cr |
P/B Ratio | 7.03 |
EPS | 8.38 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 6.54 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹195.77 Cr | 165.15% | 0.50 | ₹9 Cr | ₹188 Cr | |
NA | ₹214.08 Cr | 213.48% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹905.32 Cr | 817.04% | 0.65 | ₹23 Cr | ₹307 Cr | |
HOLD | ₹4,202.80 Cr | 27.13% | 0.50 | ₹136 Cr | ₹623 Cr | |
BUY | ₹13,741.09 Cr | 74.1% | 0.63 | ₹405 Cr | ₹4,506 Cr |
Organisation | Parnax Lab Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Parnax Lab Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 3 Years
In the last 3 years, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.30% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 27.70% of holdings in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 3.98 Cr → 3.41 Cr (in ₹), with an average decrease of 14.3% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 50.23 Cr → 49.31 Cr (in ₹), with an average decrease of 1.8% per quarter
Price Dip
In the last 7 days, Parnax Lab stock has moved down by -4.6%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.3% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 27.7% | 0.00 | |
Others | 0% | 0.00 |
Parnax Lab Ltd in the last 5 years
Lowest (-82.38x)
May 26, 2021
Today (16.42x)
December 6, 2024
Industry (57.44x)
December 6, 2024
Highest (177.62x)
February 9, 2021
Parnax Lab Ltd’s net profit jumped 82.35% since last year same period to ₹3.41Cr in the Q2 2024-2025. On a quarterly growth basis, Parnax Lab Ltd has generated -14.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Parnax Lab Ltd is currently in a Bullish trading position according to technical analysis indicators.
Parnax Lab Ltd (506128) share price today is ₹168.95
Parnax Lab Ltd is not listed on NSE
Parnax Lab Ltd is listed on BSE
PE Ratio of Parnax Lab Ltd is 16.42
PE ratio = Parnax Lab Ltd Market price per share / Parnax Lab Ltd Earnings per share
Today’s traded volume of Parnax Lab Ltd(506128) is 8,278.00.
Today’s market capitalisation of Parnax Lab Ltd(506128) is ₹195.77Cr.
Parnax Lab Ltd(506128 | Price |
---|---|
52 Week High | ₹193.5 |
52 Week Low | ₹80 |
Parnax Lab Ltd(506128) share price is ₹168.95. It is down -12.69% from its 52 Week High price of ₹193.5
Parnax Lab Ltd(506128) share price is ₹168.95. It is up 111.19% from its 52 Week Low price of ₹80
Parnax Lab Ltd(506128 | Returns |
---|---|
1 Day Returns | -1.5% |
1 Month Returns | -7.48% |
3 Month Returns | 35.21% |
1 Year Returns | 88.86% |